PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study

BACKGROUND: Post-transplant diabetes is a frequent and serious complication of kidney transplantation. There is currently no treatment to prevent or delay the disease. Nevertheless, identification of risk factors make it possible to target a population at risk of developing de novo diabetes. We hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaiffe, E., Crepin, T., Bamoulid, J., Courivaud, C., Büchler, M., Cassuto, E., Albano, L., Chemouny, J. M., Choukroun, G., Hazzan, M., Kessler, L., Legendre, C., Le Meur, Y., Ouali, N., Thierry, A., Anota, A., Nerich, V., Limat, S., Bonnetain, F., Vernerey, D., Ducloux, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588872/
https://www.ncbi.nlm.nih.gov/pubmed/31227028
http://dx.doi.org/10.1186/s13063-019-3392-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588872/
https://www.ncbi.nlm.nih.gov/pubmed/31227028
http://dx.doi.org/10.1186/s13063-019-3392-6

Ejemplares similares